Balyasny Asset Management
INZY

Balyasny Asset Management’s Inozyme Pharma INZY Stock Holding History

Balyasny Asset Management’s Portfolio INZY Stock Details INZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-39,003
Closed -$156K – 3175
2025
Q2 		$156K Buy
+39,003
New +$96.6K ﹤0.01% 2639
2024
Q2 		– Sell
-31,380
Closed -$240K – 2829
2024
Q1 		$240K Buy
+31,380
New +$172K ﹤0.01% 2339

Balyasny Asset Management's INZY Position: Q3 2025 in Review

Balyasny Asset Management sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 39,003 shares — an estimated $156K sold.

Balyasny Asset Management first reported a position in INZY in Q1 2024 and held it in 2 quarters. The position peaked at $240K in Q1 2024. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

  • Balyasny Asset Management reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 39,003 Inozyme Pharma shares in Q3 2025, an estimated $156K.
  • Balyasny Asset Management first reported a position in Inozyme Pharma in Q1 2024 and held it in 2 quarters.
  • Balyasny Asset Management's Inozyme Pharma position peaked at $240K in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on Balyasny Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.